Advertisement
Screener

INMUNE BIO INC. (INMB) Graph

INMB Revenue Flow

A current filed revenue breakdown could not be established from the retained filing evidence.

  • 2026-06-30: Revenue (m); Research and development (m); Operating expenses $1.48M; Net income -$1.27M.
  • 2026-03-31: Revenue (m); Research and development $3.64M; Operating expenses $5.81M; Net income -$5.41M.
  • 2025-12-31: Revenue $0.00*; Research and development $2.33M*; Operating expenses $5.47M*; Net income -$5.33M*.
  • 2025-09-30: Revenue (m); Research and development $4.89M; Operating expenses $7.43M; Net income -$6.47M.

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueResearch and developmentOperating expensesNet income
2026-06-30(m)(m)$1.48M-$1.27M
2026-03-31(m)$3.64M$5.81M-$5.41M
2025-12-31$0.00*$2.33M*$5.47M*-$5.33M*
2025-09-30(m)$4.89M$7.43M-$6.47M
2025-06-30(m)$5.80M$24.57M-$24.46M
2025-03-31$50.00K$7.64M$9.96M-$9.74M
2024-09-30(m)$10.07M$12.29M-$12.09M
2024-06-30(m)$7.05M$9.87M-$9.75M
2024-03-31$14.00K$8.69M$11.03M-$11.03M
2023-09-30$43.00K$5.99M$8.57M-$8.56M
2023-06-30$46.00K$4.15M$6.46M-$6.50M
2023-03-31$38.00K$4.13M$6.46M-$6.54M
2022-09-30$98.00K$5.16M$7.54M-$7.72M
2022-06-30$16.00K$4.19M$6.40M-$6.84M
2022-03-31$163.00K$4.31M$6.64M-$6.90M
2021-09-30$14.00K$6.52M$9.04M-$9.46M
2021-06-30(m)$4.46M$6.55M-$6.66M
2021-03-31$4.00K$2.49M$4.55M-$4.56M
2020-09-30(m)$2.36M$4.82M-$4.72M
2020-06-30(m)$903.00K$2.11M-$2.11M
2020-03-31(m)$793.00K$2.09M-$2.07M
2019-09-30(m)$1.17M$3.08M-$3.07M
2019-06-30$0.00$634.70K$428.42K-$392.08K
2019-03-31$0.00$612.71K$1.91M-$1.90M
2018-09-30(m)$654.69K$1.54M-$1.54M
2018-06-30$0.00$287.32K$6.17M-$6.17M
2018-03-31$0.00$104.01K$2.85M-$2.85M

Revenue and expense 6 month

Period endRevenueResearch and developmentOperating expensesNet income
2026-06-30(m)(m)$7.29M-$6.68M
2025-06-30$50.00K$13.44M$34.53M-$34.20M
2024-06-30$14.00K$15.75M$20.90M-$20.77M
2023-06-30$84.00K$8.28M$12.92M-$13.04M
2022-06-30$179.00K$8.50M$13.04M-$13.74M
2021-06-30$4.00K$6.96M$11.11M-$11.21M
2020-06-30(m)$1.70M$4.20M-$4.18M
2019-06-30$0.00$1.25M$2.34M-$2.29M
2018-06-30$0.00$391.33K$9.02M-$9.02M

Revenue and expense 9 month

Period endRevenueResearch and developmentOperating expensesNet income
2025-09-30$50.00K$18.33M$41.96M-$40.67M
2024-09-30$14.00K$25.81M$33.18M-$32.86M
2023-09-30$127.00K$14.27M$21.49M-$21.60M
2022-09-30$277.00K$13.66M$20.59M-$21.47M
2021-09-30$18.00K$13.47M$20.14M-$20.67M
2020-09-30(m)$4.06M$9.02M-$8.89M
2019-09-30(m)$2.42M$5.42M-$5.36M
2018-09-30(m)$2.36M$10.56M-$10.56M

Revenue and expense 12 month

Period endRevenueResearch and developmentOperating expensesIncome taxNet income
2025-12-31$50.00K$20.66M$47.43M(m)-$46.00M
2024-12-31$14.00K$33.17M$42.65M(m)-$42.00M
2023-12-31$155.00K$20.27M$29.90M(m)-$30.00M
2022-12-31$374.00K$17.07M$26.32M(m)-$27.30M
2021-12-31$181.00K$20.54M$29.33M(m)-$30.34M
2020-12-31$11.00K$5.92M$12.24M(m)-$12.10M
2019-12-31(m)$3.28M$7.76M(m)-$7.68M
2018-12-31$0.00$3.35M$12.44M$0.00-$12.44M
2017-12-31$0.00$435.36K$981.48K$0.00-$831.49K

Similar stocks

Stock NameCountryMarket CapPE Ratio
ImageneBio, Inc. (IMA)United States$0.056B-1.31
BioAtla, Inc. (BCAB)United States$0.058B-0.21
EXOZYMES INC. (EXOZ)United States$0.058B
Tevogen Inc. (TVGN)United States$0.049B
MiNK Therapeutics, Inc. (INKT)United States$0.063B-5.37
Instil Bio, Inc. (TIL)United States$0.048B-1.73
LeonaBio, Inc. (LONA)United States$0.047B-0.61
Eloxx Pharmaceuticals, Inc. (ELOX)United States$0.065B
Metagenomi Therapeutics, Inc. (MGX)United States$0.044B-0.48
BioStem Technologies, Inc. (BSEM)United States$0.069B